+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Product, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Drug Class (Steroidal drugs, Anti-VEGF Agents), Disease, Dosage Form, Route of Administration, Product Type, Product, Region, and Segment Forecasts, 2024-2030

  • Report
  • January 2024
  • 125 Pages
  • Global
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Prostate Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Prostate Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 121 Pages
  • Global
From
Drug Manufacturing Sector Scorecard - Thematic Intelligence - Product Thumbnail Image

Drug Manufacturing Sector Scorecard - Thematic Intelligence

  • Report
  • October 2022
  • 23 Pages
  • Global
From
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 417 Pages
  • Global
From
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 1834 Pages
  • Global
From
Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Metastatic Melanoma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Metastatic Castration Resistant Prostate cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Castration Resistant Prostate cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Basal Cell Carcinoma Treatment Global Market Report 2024 - Product Thumbnail Image

Basal Cell Carcinoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Merkel Cell Carcinoma Treatment Global Market Report 2024 - Product Thumbnail Image

Merkel Cell Carcinoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Melanoma Drugs Global Market Report 2024 - Product Thumbnail Image

Melanoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Melanoma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Melanoma Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 62 Pages
  • Global
From
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 925 Pages
  • Global
From
Follicular Lymphoma Treatment Global Market Report 2024 - Product Thumbnail Image

Follicular Lymphoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator